Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Tuesday, August 5, 2025

Lucintel Forecasts the Global Non-Invasive Blood Pressure Analyzer Market to Grow with a CAGR of 6.5% from 2025 to 2031

According to a market report by Lucintel, the future of the global non-invasive blood pressure analyzer market looks promising with opportunities in the disease model, drug development, and hypertension field research markets. The global non-invasive blood pressure analyzer market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of cardiovascular diseases, the rising demand for remote patient monitoring, and the growing focus on preventive healthcare solutions.

A more than 150-page report to understand trends, opportunity and forecast in global non-invasive blood pressure analyzer market to 2031 by type (single channel and multi-channel), application (disease model, drug development, hypertension field research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, multi-channel is expected to witness higher growth over the forecast period.

Within the application category, hypertension field research is expected to witness the highest growth.

Download sample by clicking on non-invasive blood pressure analyzer market.

In terms of region, APAC is expected to witness the highest growth over the forecast period.

Softron, Moor Instruments, IITC Life Science, Visitech Systems, Kent Scientific, Muromachi Kikai, Nanjing Calvin Biotech, Beijing Zhishu Duobao Biotech, Alaska Technology, Anhui Yaokun Biotech are the major suppliers in the non-invasive blood pressure analyzer market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Cytological Biopsy Needle Market

Embryo Biopsy Medium Market

Endometrial Biopsy Brush Market

Endomyocardial Biopsy Forcep Market

EUS-Guided Fine Needle Biopsy Market

No comments:

Post a Comment